Skip to main content
. 2011 May 1;17(5):BR147–BR152. doi: 10.12659/MSM.881761

Table 3.

Percentage of false susceptibility to third- and fourth-generation cephalosporins in the groups of ESBL and AmpC producers when using the microdilution method.

Antibiotic False susceptibility
CLSI criteria EUCAST criteria
Breakpoint (mg/L) ESBL strains (%) AmpC strains (%) Breakpoint (mg/L) ESBL strains (%) AmpC strains (%)
Cefoperazone ≤16 21 76 not stated
Cefotaxime ≤8 29 67 ≤1 7 43
Ceftazidime ≤8 32 29 ≤1 5 5
Cefepime ≤8 60 ≤1 8